Hasil Pencarian - Ranit D'Rozario

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19

    Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19 oleh Daizee Talukdar, Purbita Bandopadhyay, Yogiraj Ray, Shekhar Ranjan Paul, Jafar Sarif, Ranit D’Rozario, Abhishake Lahiri, Santanu Das, Debaleena Bhowmick, Shilpak Chatterjee, Bhabatosh Das, Dipyaman Ganguly

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Piezo1 mechanosensing regulates integrin-dependent chemotactic migration in human T cells

    Piezo1 mechanosensing regulates integrin-dependent chemotactic migration in human T cells oleh Chinky Shiu Chen Liu, Tithi Mandal, Parijat Biswas, Md Asmaul Hoque, Purbita Bandopadhyay, Bishnu Prasad Sinha, Jafar Sarif, Ranit D'Rozario, Deepak Kumar Sinha, Bidisha Sinha, Dipyaman Ganguly

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells

    Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells oleh Deblina Raychaudhuri, Roopkatha Bhattacharya, Bishnu Prasad Sinha, Chinky Shiu Chen Liu, Amrit Raj Ghosh, Oindrila Rahaman, Purbita Bandopadhyay, Purbita Bandopadhyay, Jafar Sarif, Ranit D'Rozario, Santu Paul, Anirban Das, Diptendra K. Sarkar, Samit Chattopadhyay, Dipyaman Ganguly

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19

    Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19 oleh Ranit D’Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay, Jafar Sarif, Priyanka Mehta, Chinky Shiu Chen Liu, Bishnu Prasad Sinha, Jayasree Roy, Ritwik Bhaduri, Monidipa Das, Sanghamitra Bandyopadhyay, Shekhar Ranjan Paul, Shilpak Chatterjee, Rajesh Pandey, Yogiraj Ray, Dipyaman Ganguly

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19

    Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19 oleh Jafar Sarif, Jafar Sarif, Deblina Raychaudhuri, Ranit D’Rozario, Ranit D’Rozario, Purbita Bandopadhyay, Purbita Bandopadhyay, Praveen Singh, Praveen Singh, Priyanka Mehta, Md. Asmaul Hoque, Md. Asmaul Hoque, Bishnu Prasad Sinha, Bishnu Prasad Sinha, Manoj Kushwaha, Shweta Sahni, Priti Devi, Priti Devi, Partha Chattopadhyay, Partha Chattopadhyay, Shekhar Ranjan Paul, Yogiraj Ray, Yogiraj Ray, Kausik Chaudhuri, Sayantan Banerjee, Debajyoti Majumdar, Debajyoti Majumdar, Bibhuti Saha, Biswanath Sharma Sarkar, Prasun Bhattacharya, Shilpak Chatterjee, Sandip Paul, Pramit Ghosh, Rajesh Pandey, Rajesh Pandey, Shantanu Sengupta, Shantanu Sengupta, Dipyaman Ganguly, Dipyaman Ganguly

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19

    Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19 oleh Deblina Raychaudhuri, PhD, Purbita Bandopadhyay, MS, Ranit D’Rozario, MS, Jafar Sarif, MS, Yogiraj Ray, MBBS, MD, DM, Shekhar Ranjan Paul, MBBS, DTCD, Praveen Singh, MS, Kausik Chaudhuri, MBBS, MD, Ritwik Bhaduri, MS, Rajesh Pandey, PhD, Prasun Bhattacharya, MBBS, MD, Shantanu Sengupta, PhD, Shilpak Chatterjee, PhD, Dipyaman Ganguly, MBBS, PhD

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

    A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 oleh Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Ritwik Bhaduri, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: